Skye Bioscience Inc (SKYE:NASDAQ)
$0.7204 -0.02 (-2.65%)
Analysed Skye Bioscience Inc (SKYE:NASDAQ) News Sources
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
Markets Insider
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
Le Lézard
Halozyme Therapeutics, Inc.: U.S. FDA Approves TECVAYLI in Combination with DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma
FinanzNachrichten.de
Tall, Belker and Chea lead No. 25 Princeton women over Harvard, 62-49
ESPN
Princeton 62-49 Harvard (Feb 28, 2026) Final Score - ESPN
ESPN
No. 25 Princeton Pulls Away in Second Half, Defeats Harvard 62-49
The Harvard Crimson
What is the current price of Skye Bioscience Inc (SKYE:NASDAQ)?
The current price of Skye Bioscience Inc (SKYE:NASDAQ) is $0.7204.
Skye Bioscience Inc (SKYE:NASDAQ) absolute price change since previous trading day?
The absolute price change of Skye Bioscience Inc (SKYE:NASDAQ) since the previous trading day is $-0.02.
Skye Bioscience Inc (SKYE:NASDAQ) percentage price change since previous trading day?
The percentage price change of Skye Bioscience Inc (SKYE:NASDAQ) since the previous trading day is -2.65%.
What is This Week's average sentiment score for Skye Bioscience Inc (SKYE:NASDAQ)?
This Week's average sentiment score for Skye Bioscience Inc (SKYE:NASDAQ) is 65 out of 100.
What is This Week's average sentiment for Skye Bioscience Inc (SKYE:NASDAQ)?
This Week's sentiment for Skye Bioscience Inc (SKYE:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.